Диссертация (1154843), страница 28
Текст из файла (страница 28)
37. — P. 217–233.230. Groothuis J. R. The definition and treatment of bronchopulmonary dysplasia in infants withvery low body weight at birth of newborns / J. R. Groothuis, D. Makari // Pediatr. Pulmonol. - 2013. Vol. 48. -№ 1. - P. 8-13.136231.
Guimaraes H. Respiratory outcomes and atopy in school-age children who were preterm atbirth, with and without bronchopulmonary dysplasia / H. Guimaraes, G. Rocha, S, Pissarra et al. //Clinics. – 2011. -№66(3). – Р.425-430.232. Hall C. B. The Burden of Respiratory Syncytial Virus Infection in Young Children / C. B.
Hall,G. A. Weinberg, M. K. Iwane et al // N. Engl. J. Med. — 2009. - №360. – Р.588–598.233. Hallman M. The surfactant system protects both fetus and newborn / M. Hallman //Neonatology. -2013. –V.103(4). – P.320-326.234. Halvorsen T. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohortstudy / T. Halvorsen, B.T. Skadberg, G.E. Eide et al. // Acta Paediatr.
– 2004. - №93. – Р. 1294–1300.235. Heldt G.P. Development of stability of the respiratory system in preterm infants / G.P. Heldt // JAppl Physiol. – 1988. - №65(1). –Р.441–444.236. Henderson J. Hospitalization for RSV bronchiolitis before 12 months of age and subsequentasthma, atopy and wheeze: A longitudinal birth cohort study / J. Henderson, T. N. Hilliard, A.Sherriff et al. // Pediatr. Allergy. Immunol. — 2005. - №16.
–Р.386–392.237. Henderson-Smart D.J. Prophylactic methylxanthines for endotracheal extubation in preterminfants / D.J. Henderson-Smart, P.G. Davis // Cochrane Database Syst. Rev. – 2010. :CD000139.238. Hilgendorff A. Chronic lung disease in the preterm infant. Lessons learned from animal models/ A . Hilgendorff, I. Reiss, H. Ehrhardt, et al. // Am J Respir Cell Mol Biol. – 2014.
- №50(2). –Р.233–245.239.Hjalmarson О. Persisting hypoxaemia is an insufficient measure of adverse lungfunction in very immature infants / O. Hjalmarson, H. Brynjarsson, S. Nilsson, et al // Arch DisChild Fetal Neonatal Ed. – 2014. - №99. – Р.257–262.240. Hoo A.F. Development of airway function in infancy after preterm delivery / A.F. Hoo, C.Dezateux, M. Henschen, et al // J Pediatr. – 2002. - №141(5).
– Р.652–658.241. Horbar J.D. Trends in mortality and morbidity in very low birth weight, 1991-1999 / J.D.Horbar, G.J. Badger, J.H. Carpenter, et al // J Pediatrics. – 2002. - №110. – Р.143-151.242.Howling S.J. Pulmonary sequelae of bronchopulmonary dysplasia survivors:high-resolution CT findings / S.J.
Howling, W.H.Jr. Northway, D.M. Hansell et al. // Am JRoentgenol. - 2000. - №174. – Р.1323–1326.243. Hussain N. A. Pathology of arrested acinar development in postsurfactant bronchopulmonarydysplasia / N. A. Hussain, N. H. Siddiqui, J. R. Stocker // Hum Pathol. — 1998. — Vol.
29. — P.710—717.244. Hyde I. The chanding pattern of chronic lung disease of prematurity / I. Hyde, R. E. English, J.E. Williams // Arch. Dis. Child. — 1989. — V. 64. — Р. 448–451.245. Hyo Soon, Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia /Hyo Soon An, Eun Jung Bae, Gi Beom Kim, et al // Korean Circ J.
– 2010, Mar. - №40(3). – Р.131136.246. Hyödynmaa E.Frequency and clinical correlation with radiologic changes ofbronchopulmonary dysplasia in infants with very low birth weight / E. Hyödynmaa, P. Korhonen, S.Ahonen et al. // Eur J Pediatr. - 2012. - Vol. 171. - № 1. - P. 95-102.247. Ionescu L. Stem cell conditioned medium improves acute lung injury in mice: In vivo evidencefor stem cell paracrine action / L.
Ionescu, R.N. Byrne, T. van Haaften, et al. // Am J Physiol LungCell Mol Physiol. – 2012. –№303. – Р.967–977.248. Jobe A. Antenatal infection/inflammation and postnatal lung maturation and injury / A. Jobe,M. Ikegami // Respir Res. – 2001. - № 2. – Р.27–32.249. Jobe A. H. Bronchopulmonary dysplasia / A. H. Jobe, E. Bancalari // Am. J.
Respir. Crit. CareMed. — 2001. — V. 163. — Р. 1723–1729.250. Jobe A.J. The new BPD: an arrest of lung development / A.J. Jobe //Pediatr Res. – 1999. №46(6). – Р.641–643.251. Jobe, A.H. Antenatal factors and the development of bronchopulmonary dysplasia / A.H. Jobe//Semin. Neonatol. – 2003. – V. 8(1). – P. 917.137252. Jonsson B . Neonatal Ureaplasma urealyticum colonissation and chronic lung disease /JonssonB.
et al. //Acta Pediat. – 1994. – V. 83. – P. 927-930.253. Kaplan E. Encouraging pulmonary outcome for surviving, neurologically intact, extremelypremature infants in the postsurfactant era. / E. Kaplan, E. Bar-Yishay, D. Prais, et al // Chest. –2012. - № 142(3). – Р.725–733.254. Kevill K. A. New bronchopulmonary dysplasia and long-term airway dysfunction / K.A.Kevill, R. L. Auten, E. D. Schultz // Neonatal Respir. Dis. -2007. –V.17 (2). –P.
1-8.255. Kim D.H. Risk factors for pulmonary artery hypertension in preterm infants with moderate orsevere bronchopulmonary dysplasia / D.H. Kim, H.S. Kim, C.W. Choiet al. // Neonatology. -2012.– V.101(1). –P.40–46.256. King V.J. Pharmacologic treatment of bronchiolitis in infants and children / V.J. King, M.Viswanathan, W.C. Bordley, et al.
// Arch Pediatr Adolesc Med. – 2004. – № 158. – P. 127–137.257. Kjellberg A.T. Randomized single versus double embryo transfer: obstetric and pediatricsoutcome and a cost-effectiveness analysis / A.T. Kjellberg, P.Carlsson , C. Bergh et al. // HumReprod/ -2006. – V.21(1). –P. 210—216.258. Koivurova S. Growth, psychomotor development and morbidity up to 3 years of age inchildren born after IVF / S.Koivurova , A.L.Hartikainen , U.Sovio et al. // Hum Reprod. 2003. –V.18.
–P. 2328—2336.259. Konefał H.School-age spirometry in survivors of chronic lung disease of prematurity in thesurfactant era // H. Konefał, M.B. Czeszyńska, T.A. Merritt // Ginekol Pol. -2013. –V.84(4). –P.28692.260. Kotecha S., Pulmonary Ureaplasma urealyticum is associated with the development of acutelung inflammation and chronic lung disease in preterm in fants /Kotecha S., Hodge R., Schaber J.A.et al. //Pediat. Res. – 2004. – V. 55.
– P. 6168.261. Kourembanas S. New Therapies For Pulmonary Hypertension And Bpd – From Bench ToBedside / S. Kourembanas, K. Sdrimas, C.J. Lee, et al // Arch Dis Child. - 2014. - №99262. Kusuda S. Morbidity and mortality of infants with very low birth weight in Japan: centervariation / S. Kusuda // Pediatrics. - 2006. - Vol. 118. - P. 1130-1138.263. Kwinta P. The prevalence and risk factors of allergic and respiratory symptoms in a regionalcohort of extremely low birth weight children (<1000 g) / P.
Kwinta, G. Lis, M. Klimek, A. Grudzienet al. // Italian Journal of Pediatrics. -2013. – V.39(4). –P.1-11.264.Lamarche-Vadel A. Re-hospitalization in infants younge than 29 weeksgestation in the EPIPAGE cogort / A. Lamarche-Vadel, B. Blondel, P. Truffer et al. // Acta Pediatr.-2004. –V.93. – P.1340-1345.265.Landry J.S. Long-term impact of bronchopulmonary dysplasia on pulmonaryfunction / JS Landry, T Chan, L Lands, D Menzies // Can Respir J. -2011. –V.18(5).
–P.265-270.266.Latini G. The Pulse Oximeter Perfusion Index as a Predictor for High IllnessSeverityinNeonates/G. Latini, C. De Felice, P.Vacca, et al. //.J. Eur J Pediatr. -2002, Oct. – V.161(10). –P.561-562.267. Le Blanc K. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graftversus-host disease: A phase II study / K.
Le Blanc, F. Frassoni, L. Ball, et al. // Lancet. -2008. –V.371. –P.1579–1586.268.Lefkowitz W. Bronchopulmonary dysplasia: pathway from disease to long-termoutcome / W. Lefkowitz, S.H. Rosenberg //J Perinatol. -2008. –V. 28(12). –P.837–840.269. Lemyre B., Update Cochrane review: comparative analysis of the use of two modes ofmechanical ventilation nasal intermittent positive (NIPPV) and continuous positive airway pressure(NCPAP) in preterm infants after extubation / B. Lemyre, P.G.Davis, A.G. De Paoli et al. // CochraneDatabase.
Syst Rev. – 2014; 9: CD003212.270. Lenton S. Prevalence of non-malignant life-threaening illness // S. Lenton, D. Stallard, J.Lewis, P. Mastroyannopolou // Child Care Health and Dev. -2001. –V.27 (5). –P. 389–397.271. Levine D.A. Multicenter RSV-SBI Study Group of the Pediatric Emergency MedicineCollaborative Research Committee of the American Academy of Pediatrics. Risk of serious bacterial138infection in young febrile infants with respiratory syncytial virus infections / D.A.
Levine, S.L. Platt,P.S. Dayan, et al. // Pediatrics. – 2004. – № 113(6). – P. 1728-1734.272. Lu Y. Long-term followup of children conceived through assisted reproductive technology/ Y.Lu et al. // J Zhejiang Univ Sci B. -2013. –V.14(5).
–P.359—371.273.Mabanta C. Erythromycin for the prevention of chronic lung disease inintubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum / C.Mabanta, G. Pryhuber, G. Weinberg, et al // Cochranre Database Syst. Rev. – 2003.274.
Madurga A . Recent advances in late lung development and the pathogenesis ofbronchopulmonary dysplasia // A. Madurga, I. Mizikova, J. Ruiz-Camp, R.E. Morty // Am J PhysiolLung Cell Mol Physiol. -2013. –V.305(12). –P.893–905.275. Maniscalco W.M. Hyperoxic ventilated premature baboons have increased p53, oxidant DNAdamage and decreased VEGF expression / W.M.
Maniscalco, R.H. Watkins, J.M. Roper, et al. //Pediatr Res. -2005. –V.58(3). –P.549–556.276. Manktelow B.N. Factors affecting the incidence of chronic lung disease of prematurity in 1987,1992 and 1997 / B.N. Manktelow, E.S. Draper, S. Annemelei, et al. // Arch. Dis. Child. -2001. –V.85. –P.33–35.277. Markestad T.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
